Citation Impact
Citing Papers
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
2010 Standout
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
2004 Standout
THE INDEPENDENT EFFECTS OF HYPERANDROGENAEMIA, HYPERINSULINAEMIA, AND OBESITY ON LIPID AND LIPOPROTEIN PROFILES IN WOMEN*
1990
A Survey of the Polycystic Ovary Syndrome in the Greek Island of Lesbos: Hormonal and Metabolic Profile
1999
Transvaginal sonography and abnormal ovarian appearance in menstrual cycle disturbances
1991
Endoscopic Therapy for Bleeding Ulcers: An Evidence-Based Approach Based on Meta-Analyses of Randomized Controlled Trials
2008
Hyperandrogenism in Polycystic Ovary Syndrome -- Evidence of Dysregulation of 11β-Hydroxysteroid Dehydrogenase
1994
Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women
1998
Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report
2007 Standout
Trends in Acute Nonvariceal Upper Gastrointestinal Bleeding in Dialysis Patients
2012 Standout
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study1
1998 Standout
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Relevance of the determination of ovarian volume in adolescent girls with menstrual disorders
1996
Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries
2005
How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?
1992
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome
2004
de Lange syndrome: A clinical review of 310 individuals
1993 Standout
Longitudinal Change of Sonographic Ovarian Aspects and Endocrine Parameters in Irregular Cycles of Adolescence
1995
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Dual Therapy Versus Monotherapy in the Endoscopic Treatment of High-Risk Bleeding Ulcers: A Meta-Analysis of Controlled Trials
2007
Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine–metabolic and ultrasonographic differences
2002
Results of an Open One‐Year Study with Diane‐35 in Women with Polycystic Ovarian Syndrome
1993
Portal hypertensive bleeding in cirrhosis
2016 Standout
Heritability and the risk of developing androgen excess
1999
Polycystic ovarian disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis
1991
Polycystic Ovary Syndrome
1995 Standout
Ovarian Volume throughout Life: A Validated Normative Model
2013
Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses
2009
The Efficacy and Safety of Gonadotropin-Releasing Hormone Analog Treatment in Childhood and Adolescence: A Single Center, Long-Term Follow-Up Study
2009
8 Definition and significance of polycystic ovaries
1997
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Endocrine Determinants of Fertility: Serum Androgen Concentrations during Follow-up of Adolescents into the Third Decade of Life*
1990
Reproductive endocrinology of adolescent polycystic ovary syndrome
2009
Ultrasound assessment of the polycystic ovary: international consensus definitions
2003
Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus
2006
Management of Patients With Ulcer Bleeding
2012 Standout
Polycystic Ovary Syndrome
2005 Standout
Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome
1994
Clinical and Hormonal Characteristics of Obese Amenorrheic Hyperandrogenic Women Before and After Weight Loss*
1989
Malformations and minor anomalies in non‐trisomic, autosomal aneuploidy
1993
The prevalence of polycystic ovaries in women with type 2 diabetes mellitus
2000
The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long‐term oestrogen–progestagen treatment
1999
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio
2001
A MELD-Based Model to Determine Risk of Mortality Among Patients With Acute Variceal Bleeding
2013
Polycystic ovary syndrome
2016 Standout
Inappropriate Gonadotropin Secretion in Polycystic Ovary Syndrome: Influence of Adiposity1
1997
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women1
1999 Standout
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Estrogenic ovulatory dysfunction or functional female hyperandrogenism: an argument to discard the term polycystic ovary syndrome
2006
Protein therapeutics: a summary and pharmacological classification
2007 Standout
The relative contribution of androgens and insulin in determining abdominal body fat distribution in premenopausal women
1991
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria
2009 Standout
The influence of antenatal exposure to phthalates on subsequent female reproductive development in adolescence: a pilot study
2013
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Tissue adhesives: cyanoacrylate glue and fibrin sealant
2013
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children
2009
Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification
1995
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Comparative Effects of Cyproterone Acetate or a Long-Acting Gonadotropin-Releasing Hormone Agonist in Polycystic Ovarian Disease
1986
Polycystic ovaries and associated clinical and biochemical features in young women
1999
A Survey of the Polycystic Ovary Syndrome in the Greek Island of Lesbos: Hormonal and Metabolic Profile
1999
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1
2000 Standout
Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists.
1992
Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage
2016
Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study
2013
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Correlation of the ultrasonic appearance of the ovaries in polycystic ovarian disease and the clinical, hormonal, and laparoscopic findings
1986
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Standards for ovarian volume in childhood and puberty
1993
Works of L. Orsini being referenced
Uncommon cause of early postoperative colonic fistula successfully treated with endoscopic acrylate glue injection
2007
Prenatal karyotyping in malformed fetuses
1990
The Effectiveness of Current Acute Variceal Bleed Treatments in Unselected Cirrhotic Patients: Refining Short-Term Prognosis and Risk Factors
2012
Reproductive outcome in patients treated and not treated for idiopathic early puberty: Long-term results of a randomized trial in adults
2006
Combined epinephrine and bipolar probe coagulation vs. bipolar probe coagulation alone for bleeding peptic ulcer: a randomized, controlled trial
2004
Ovaries and Menstrual Cycles in Adolescence
1984
Ovarian multifollicularity, high LH and androgen plasma levels, and anovulation are frequent and strongly linked in adolescent irregular cycles
1986
Pelvic ultrasonography in premenarcheal girls: relation to puberty and sex hormone concentrations.
1985
Ultrasound monitoring of ovarian follicular development: A comparison of real‐time and static scanning techniques
1983
Ultrasonic findings in polycystic ovarian disease
1985
Ovarian Multifollicularity, High LH and Androgen Plasma Levels, and Anovulation Are Frequent and Strongly Linked in Adolescent Irregular Cycles
1986